Skip to main content
Caplight Logo









Taichu Group

Taichu Group

Private
ShanghaiHealthcare & Life Scienceshttps://www.taichubio.com/

Last Round

Series B

Mar 1, 2025

Total Funding Raised

$101.3M

Company Overview

Taichu Group is a biotechnology company that provides an integrated contract research, development, and manufacturing organization (CRDMO) platform for preclinical drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Contract Research OrganizationCROContract Development and Manufacturing OrganizationCDMOIntegrated CRO CDMOBiologics CDMODrug discovery servicesPreclinical researchAntibody discoveryGMP manufacturingNucleic acid drug developmentOligonucleotide CDMOBiopharmaceutical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Taichu Group Comparables

Compare Taichu Group with similar companies based on industry and business-model similarity.

Taichu Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ChemPartner PharmaTech
83%
Shanghai Medicilon Inc.
82%
WuXi Biologics
82%

Taichu Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2025
Series A ExtensionMar 8, 2024
Series AMay 8, 2023
Pre SeedAug 15, 2022
AngelJul 18, 2022
Seed
Oct 28, 2020

Taichu Group Investors

Notable investors and investment history

Taichu Group investors
InvestorRounds
IDG CapitalSeries A
TF CapitalAngel
上实投资(上海)有限公司Seed
Tigeryeah CapitalSeries A Extension
Yijing CapitalSeries A
Fortera CapitalSeries A Extension
Juntong CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    Completed a Series B funding round.

  • Mar 8, 2024

    Raised Series A Extension with Fortera Capital and Tigeryeah Capital.

Taichu Group Filings

Explore SEC and related filing metadata, where available.

Taichu Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Taichu Group's valuation, stock price, and market status.

Is Taichu Group a public or private company?

Taichu Group is a private company.

What is the current stock price of Taichu Group?

Taichu Group is a private company with no public stock price. No recent secondary market data is available.

How much is Taichu Group worth (valuation)?

Valuation information for Taichu Group is not publicly available.

Can I buy Taichu Group stock?

Taichu Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Taichu Group's last funding round?

Funding round information for Taichu Group is not publicly available.

Who are the main investors in Taichu Group?

Investor information for Taichu Group is not publicly disclosed.

Will Taichu Group IPO soon?

No public IPO plans have been announced for Taichu Group.

How can I track Taichu Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Taichu Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2020
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?